Literature DB >> 1332683

Primary structure and receptor-binding properties of a neurokinin A-related peptide from frog gut.

Y Wang1, T Badgery-Parker, S Lovas, N Chartrel, H Vaudry, E Burcher, J M Conlon.   

Abstract

A tachykinin peptide was isolated from an extract of the intestine of the European green frog, Rana ridibunda, and its primary structure was established as: His-Lys-Leu-Asp-Ser-Phe-Ile-Gly-Leu-Met.CONH2. This sequence was confirmed by chemical synthesis and shows two amino acid substitutions (leucine for threonine at position 3 and isoleucine for valine at position 7) compared with neurokinin A. Binding parameters for synthetic [Leu3,Ile7]neurokinin A and mammalian tachykinins were compared using receptor-selective radioligands and crude membranes from tissues enriched in the NK1, NK2 and NK3 receptors. [Leu3,Ile7]Neurokinin A was approx. 3-fold less potent than substance P in inhibiting the binding of 125I-labelled [Sar9,Met(O2)11]substance P (labelled with Bolton-Hunter reagent) to rat submandibular gland (NK1 receptor), 8-fold less potent than neurokinin A in inhibiting the binding of [2-[125I]iodohistidine1]neurokinin A to rat stomach fundus (NK2 receptor) and 6-fold less potent than neurokinin B in inhibiting the binding of 125I-Bolton-Hunter-labelled scyliorhinin II to rat brain (NK3 receptor). Thus the frog neurokinin A-related peptide shows moderate affinity but lack of selectivity for all three tachykinin-binding sites in rat tissues. This non-selectivity is similar to that displayed by the molluscan tachykinin, eledoisin, which also contains an isoleucine residue in the corresponding position in the molecule.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332683      PMCID: PMC1133082          DOI: 10.1042/bj2870827

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Characterization of the cDNA encoding proopiomelanocortin in the frog Rana ridibunda.

Authors:  E Hilario; I Lihrmann; H Vaudry
Journal:  Biochem Biophys Res Commun       Date:  1990-12-14       Impact factor: 3.575

2.  Multiple tachykinin binding sites in hamster, rat and guinea-pig urinary bladder.

Authors:  E Burcher; S H Buck
Journal:  Eur J Pharmacol       Date:  1986-09-09       Impact factor: 4.432

3.  Scyliorhinin I and II: two novel tachykinins from dogfish gut.

Authors:  J M Conlon; C F Deacon; L O'Toole; L Thim
Journal:  FEBS Lett       Date:  1986-05-05       Impact factor: 4.124

4.  Causal links between plasma and CSF endorphin levels in stress: vector-ARMA analysis.

Authors:  D B Carr; K J Jones; R M Bergland; A Hamilton; N W Kasting; J E Fisher; J B Martin
Journal:  Peptides       Date:  1985       Impact factor: 3.750

5.  The dogfish peptides scyliorhinin I and scyliorhinin II bind with differential selectivity to mammalian tachykinin receptors.

Authors:  S H Buck; J L Krstenansky
Journal:  Eur J Pharmacol       Date:  1987-11-24       Impact factor: 4.432

6.  Carassin: a tachykinin that is structurally related to neuropeptide-gamma from the brain of the goldfish.

Authors:  J M Conlon; F O'Harte; R E Peter; O Kah
Journal:  J Neurochem       Date:  1991-04       Impact factor: 5.372

7.  Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain.

Authors:  M M Dietl; J M Palacios
Journal:  Brain Res       Date:  1991-01-25       Impact factor: 3.252

8.  Ranakinin: a novel NK1 tachykinin receptor agonist isolated with neurokinin B from the brain of the frog Rana ridibunda.

Authors:  F O'Harte; E Burcher; S Lovas; D D Smith; H Vaudry; J M Conlon
Journal:  J Neurochem       Date:  1991-12       Impact factor: 5.372

9.  Antisera raised against eledoisin and kassinin detect immunoreactive material in rat tissue extracts: tissue distribution and chromatographic characterization.

Authors:  E Theodorsson-Norheim; E Brodin; I Norheim; S Rosell
Journal:  Regul Pept       Date:  1984-11

10.  Multiple tachykinin binding sites in peripheral tissues and in brain.

Authors:  C M Lee; N J Campbell; B J Williams; L L Iversen
Journal:  Eur J Pharmacol       Date:  1986-11-04       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.